Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-16-135724)

Filing Details

Accession Number:: 0001209191-16-135724
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-08-05 17:01:46
Reporting Period:: 2016-08-03

Filing Date:: 2016-08-05
Accepted Time:: 2016-08-05 17:01:46
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1326732	Xencor Inc	XNCR	Pharmaceutical Preparations (2834)	201622502

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1591213	A Paul Foster	C/O Xencor, Inc. 111 West Lemon Avenue Monrovia CA 91016	Chief Medical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2016-08-03	5,000	$4.25	7,419	No	4	M	Direct
Common Stock	Disposition	2016-08-03	5,000	$20.01	2,419	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2016-08-03	5,000	$0.00	5,000	$4.25

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
14,778		2023-09-03	No	4	M	Direct

Footnotes

Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted November 23, 2015.
25% of the shares subject to the option shall vest on the one year anniversary of September 4, 2013 (the "Vesting Commencement Date"), and 1/48th of the shares shall vest monthly thereafter, such that the option shall be fully vested and exercisable on the four year anniversary of the Vesting Commencement Date.